TITLE

Neuropathic pain: a practical guide for the clinician

AUTHOR(S)
Gilron, Ian; Watson, C. Peter N.; Cahill, Catherine M.; Moulin, Dwight E.
PUB. DATE
August 2006
SOURCE
CMAJ: Canadian Medical Association Journal;8/1/2006, Vol. 175 Issue 3, p265
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Neuropathic pain, caused by various central and peripheral nerve disorders, is especially problematic because of its severity, chronicity and resistance to simple analgesics. The condition affects 2%-3% of the population, is costly to the health care system and is personally devastating to the people who experience it. The diagnosis of neuropathic pain is based primarily on history (e.g., underlying disorder and distinct pain qualities) and the findings on physical examination (e.g., pattern of sensory disturbance); however, several tests may sometimes be helpful. Important pathophysiologic mechanisms include sodium- and calcium-channel upregulation, spinal hyperexcitability, descending facilitation and aberrant sympathetic--somatic nervous system interactions. Treatments are generally palliative and include conservative nonpharmacologic therapies, drugs and more invasive interventions (e.g., spinal cord stimulation). Individualizing treatment requires consideration of the functional impact of the neuropathic pain (e.g., depression, disability) as well as ongoing evaluation, patient education, reassurance and specialty referral. We propose a primary care algorithm for treatments with the most favourable risk--benefit profile, including topical lidocaine, gabapentin, pregabalin, tricyclic antidepressants, mixed serotonin--norepinephrine reuptake inhibitors, tramadol and opioids. The field of neuropathic pain research and treatment is in the early stages of development, with many unmet goals. In coming years, several advances are expected in the basic and clinical sciences of neuropathic pain, which will provide new and improved therapies for patients who continue to experience this disabling condition.
ACCESSION #
21678175

 

Related Articles

  • Depression in palliative care.  // Nursing Standard;11/26/2008, Vol. 23 Issue 12, p58 

    A questionnaire regarding depression in palliative care is presented.

  • Depression in palliative care: a systematic review. Part 2. Treatment. Lan Ly, Kelly; Addington-Hall, Julia; Chidgey, Jayne; Hotopf, Matthew // Palliative Medicine;Jul2002, Vol. 16 Issue 4, p279 

    Objective: To summarize available literature containing data on the treatment of depression in palliative care patients. Methods: A systematic review was conducted using extensive electronic databases and hand searches. All randomized controlled trials (RCTs) of interventions for depression in...

  • Which depression screening tools should be used in palliative care? Lloyd-Williams, Mari; Spiller, Juliet; Ward, Jason // Palliative Medicine;Jan2003, Vol. 17 Issue 1, p40 

    Depression is a significant symptom for many palliative care patients, but is difficult to diagnose and therefore treat. In an effort to improve detection, there has been increasing interest in the use of screening tools. Many tools, however, have been developed for physically well patients and...

  • Diarrhea in Palliative Care. Alderman, Jeffrey // Journal of Palliative Medicine;Apr2005, Vol. 8 Issue 2, p449 

    Provides information on diarrhea in palliative care. Definition and common causes of diarrhea; Factors to consider when performing a physical examination; Use of antibiotics.

  • Can Depression Be a Terminal Illness? Shuster Jr., John L.; von Gunten, Charles F. // Journal of Palliative Medicine;Winter2000, Vol. 3 Issue 4, p493 

    Illustrates the general principles of palliative medicine and describes practical approaches to clinical problem solving. Assessment of depressive symptoms in palliative care patients; Treatment of depression in the palliative care setting; Discussion on depression as a terminal illness.

  • Is the Hospital Anxiety and Depression Scale (HADS) useful in assessing depression in palliative care? Holtom, N.; Barraclough, J. // Palliative Medicine;May2000, Vol. 14 Issue 3, p219 

    Evaluates the impact of using the Hospital Anxiety & Depression Scale (HADS) in the setting of a palliative care unit on recognition and treatment of depression in Reading, England. Association of use of HADS with increased prescription of antidepressants; Acceptability to patients; Benefits of...

  • Depressive symptoms in advanced cancer. Part 2. Depression over time; the role of the palliative care professional. Martine Meyer, H.A.; Sinnott, Claire; Seed, Paul T. // Palliative Medicine;Nov2003, Vol. 17 Issue 7, p604 

    Objective: To survey changes in depressive symptoms over time in patients with advanced cancer using the Mood Evaluation Questionnaire (MEQ), and explore how effective Palliative Care Professionals (PCPs) are at assessing this. Method: Forty-five advanced cancer patients were followed monthly...

  • How do palliative medicine physicians assess and manage depression. Lawrie, Iain; Lloyd-Williams, Mari; Taylor, Fiona // Palliative Medicine;May2004, Vol. 18 Issue 3, p234 

    Depression is a significant symptom for approximately 25% of palliative care patients, but is frequently unrecognized and untreated. This study was carried out to determine how senior doctors working in palliative medicine in the UK assessed and managed depression in their patients. A...

  • Advice urges allaying fears about opioids. Berry, Lisa // Cancer Nursing Practice;Jun2012, Vol. 11 Issue 5, p5 

    The article reports the guideline published by the National Institute for Health and Clinical Excellence (NICE) on prescribing strong opioids to relieve pain in patients with advanced and progressive disease. NICE has observed that pain in palliative care is being undertreated owing to concerns...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics